Clinical Trials Browser

Phase 1 × Terminated × pegvisomant × Clear all

NCT00976508 2013-12-13

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Phase 1 Terminated

24 enrolled 10 charts

BreastGastrointestinalGenitourinarySarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms